S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
Log in
NASDAQ:KRYS

Krystal Biotech Earnings Date, Estimates & History

$71.65
-11.58 (-13.91 %)
(As of 03/4/2021 04:50 PM ET)
Add
Compare
Today's Range
$70.91
Now: $71.65
$85.00
50-Day Range
$65.05
MA: $72.02
$85.46
52-Week Range
$33.08
Now: $71.65
$87.29
Volume268,661 shs
Average Volume171,187 shs
Market Capitalization$1.59 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.2

Earnings

Krystal Biotech (NASDAQ:KRYS) Earnings Information

Krystal Biotech last announced its earnings results on February 28th, 2021. The reported ($0.53) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.61) by $0.08. Krystal Biotech has generated ($1.20) earnings per share over the last year. Krystal Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 3rd, 2021 based off prior year's report dates.

Krystal Biotech Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Krystal Biotech (NASDAQ:KRYS) Earnings Estimates

2021 EPS Consensus Estimate: ($2.61)
2022 EPS Consensus Estimate: ($2.90)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.61)($0.56)($0.59)
Q2 20212($0.69)($0.61)($0.65)
Q3 20212($0.78)($0.51)($0.65)
Q4 20212($0.88)($0.58)($0.73)
Q1 20221($0.68)($0.68)($0.68)
Q2 20221($0.71)($0.71)($0.71)
Q3 20221($0.72)($0.72)($0.72)
Q4 20221($0.79)($0.79)($0.79)

Krystal Biotech (NASDAQ KRYS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/3/2021
(Estimated)
       
2/28/202112/31/2020($0.61)($0.53)($0.53)N/A
11/14/20209/30/2020($0.47)($0.49)($0.49)Listen
8/10/2020Q2 2020($0.4540)($0.37)($0.37)N/A
5/4/20203/31/2020($0.44)($0.31)($0.31)N/A
3/10/2020Q4($0.3290)($0.31)($0.31)N/A
11/4/2019Q3 2019($0.3870)($0.25)($0.25)N/A
8/5/2019Q2 2019($0.32)($0.37)($0.37)N/A
5/7/2019Q1 2019($0.33)($0.29)($0.29)N/A
3/12/2019Q4 2018($0.24)($0.28)($0.28)N/A
11/5/20189/30/2018($0.26)($0.26)($0.26)N/A
8/6/20186/30/2018($0.34)($0.22)($0.22)N/A
5/7/20183/31/2018($0.48)($0.21)($0.21)N/A
11/13/2017Q3 2017($0.74)($1.26)($1.26)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.